Recent Updates
Recently added Catalysts
PTCT Neutral Sentiment Score: 55/100

PTC Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that CEO Matthew B. Klein, M.D., will present at the 44th Annual J.P. Morgan Healthcare...

Key Takeaway: PTC Therapeutics, Inc. has announced that CEO Matthew B. Klein, M.D., will be presenting at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. The presentation is scheduled for 9 a.m. PST/12 p.m. EST and will be webcast live. Interested participants can access the presentation via the company's website, and it will remain available for 30 days post-event. This event highlights the company's ongoing engagement with investors and the healthcare community.

Market Sentiment Analysis

POSITIVE FACTORS

  • PTC Therapeutics is participating in a prestigious healthcare conference.
  • The presentation will be accessible live and archived for future viewing.

Full Press Release Details

WARREN, N.J. , Dec. 18, 2025 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that CEO Matthew B. Klein, M.D., will present at the 44 th Annual J.P. Morgan Healthcare Conference on Monday, Jan. 12, 2026, at 9 a.m. PST/12 p.m. EST.
The presentation will be webcast live on the Events and Presentations page of the Investors section of the PTC Therapeutics website at https://ir.ptcbio.com/events-presentations, and it will be archived for 30 days following the presentation.
For More Information:
Investors: Ellen Cavaleri +1 (615) 618-6228 [email protected]
Media: Jeanine Clemente +1 (908) 912-9406 [email protected]
SOURCE PTC Therapeutics, Inc.

21 %

Frequently Asked Questions

When is PTC Therapeutics presenting at the J.P. Morgan Conference?

PTC Therapeutics will present on January 12, 2026, at 9 a.m. PST.

Where can I watch the presentation live?

The presentation can be viewed on PTC Therapeutics' Investors page.

How long will the presentation be archived?

The presentation will be available for 30 days after the event.

Who is the CEO of PTC Therapeutics?

The CEO of PTC Therapeutics is Dr. Matthew B. Klein.

Last updated: Dec 18, 2025